| Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties C Antzelevitch, L Belardinelli, AC Zygmunt, A Burashnikov, JM Di Diego, ... Circulation 110 (8), 904-910, 2004 | 805 | 2004 |
| The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart C Antzelevitch, W Shimizu, GANXIN YAN, S Sicouri, J Weissenburger, ... Journal of cardiovascular electrophysiology 10 (8), 1124-1152, 1999 | 688 | 1999 |
| Overview of basic mechanisms of cardiac arrhythmia C Antzelevitch, A Burashnikov Cardiac electrophysiology clinics 3 (1), 23-45, 2011 | 485 | 2011 |
| Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role … A Burashnikov, JM Di Diego, AC Zygmunt, L Belardinelli, C Antzelevitch Circulation 116 (13), 1449-1457, 2007 | 466 | 2007 |
| Does Tpeak–Tend provide an index of transmural dispersion of repolarization? C Antzelevitch, S Sicouri, JM Di Diego, A Burashnikov, S Viskin, ... Heart rhythm 4 (8), 1114-1116, 2007 | 385 | 2007 |
| Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization–induced triggered activity A Burashnikov, C Antzelevitch Circulation 107 (18), 2355-2360, 2003 | 370 | 2003 |
| Electrophysiologic basis for the antiarrhythmic actions of ranolazine C Antzelevitch, A Burashnikov, S Sicouri, L Belardinelli Heart rhythm 8 (8), 1281-1290, 2011 | 255 | 2011 |
| Electrophysiologic properties and antiarrhythmic actions of a novel antianginal agent C Antzelevitch, L Belardinelli, L Wu, H Fraser, AC Zygmunt, ... Journal of cardiovascular pharmacology and therapeutics 9 (1_suppl), S65-S83, 2004 | 165 | 2004 |
| Late‐phase 3 EAD. A unique mechanism contributing to initiation of atrial fibrillation A Burashnikov, C Antzelevitch Pacing and clinical electrophysiology 29 (3), 290-295, 2006 | 162 | 2006 |
| Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia GB Nam, A Burashnikov, C Antzelevitch Circulation 111 (21), 2727-2733, 2005 | 159 | 2005 |
| Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation A Burashnikov, S Sicouri, JM Di Diego, L Belardinelli, C Antzelevitch Journal of the American College of Cardiology 56 (15), 1216-1224, 2010 | 154 | 2010 |
| Acceleration‐induced action potential prolongation and early afterdepolarizations A Burashnikov, C Antzelevitch Journal of cardiovascular electrophysiology 9 (9), 934-948, 1998 | 153 | 1998 |
| Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation A Burashnikov, A Petroski, D Hu, H Barajas-Martinez, C Antzelevitch Heart Rhythm 9 (1), 125-131, 2012 | 104 | 2012 |
| Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation C Antzelevitch, A Burashnikov Journal of electrocardiology 42 (6), 543-548, 2009 | 103 | 2009 |
| Transmembrane action potential heterogeneity in the canine isolated arterially perfused right atrium: effect of IKr and IKur/Ito block A Burashnikov, S Mannava, C Antzelevitch American Journal of Physiology-Heart and Circulatory Physiology 286 (6 …, 2004 | 103 | 2004 |
| Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria S Sicouri, A Burashnikov, L Belardinelli, C Antzelevitch Circulation: Arrhythmia and Electrophysiology 3 (1), 88-95, 2010 | 92 | 2010 |
| Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation A Burashnikov, JM Di Diego, S Sicouri, M Ferreiro, L Carlsson, ... Heart Rhythm 5 (12), 1735-1742, 2008 | 90 | 2008 |
| Can inhibition of IKur promote atrial fibrillation? A Burashnikov, C Antzelevitch Heart Rhythm 5 (9), 1304-1309, 2008 | 77 | 2008 |
| Prominent IKs in Epicardium and Endocardium Contributes to Development of Transmural Dispersion of Repolarization but Protects Against Development of Early … A Burashnikov, C Antzelevitch Journal of cardiovascular electrophysiology 13 (2), 172-177, 2002 | 75 | 2002 |
| New developments in atrial antiarrhythmic drug therapy A Burashnikov, C Antzelevitch Nature Reviews Cardiology 7 (3), 139-148, 2010 | 73 | 2010 |
Charles AntzelevitchDistinguished Professor and Executive Director, Cardiovascular Research, Lankenau Institute forVerified email at mlhs.org
